Latest News about FDA
Recent news which mentions FDA
Johnson & Johnson's Abiomed Unit Recalls Instructions For Some Impella Blood Pumps Due To Cutting Risks
March 21, 2024
From Benzinga
FDA Probe On China-Made Syringes: Becton Dickinson Boosts US Syringe Output Following Concerns
March 21, 2024
From Benzinga
From Benzinga
FDA Adcomm Favors Expanded Use Of Johnson & Johnson, Bristol Myers' CAR-T Therapies For Type Of Blood Cancer
March 18, 2024
From Benzinga
VP Kamala Harris Urges DEA To Reschedule Cannabis 'As Quickly As Possible,' Calls Prohibition 'Absurd' & 'Unfair'
March 15, 2024
From Benzinga
From Benzinga
FDA Approves BeiGene's First Drug Candidate Produced Through Its Immuno-Oncology Program For Esophageal Cancer
March 15, 2024
From Benzinga
FDA Approves Intuitive Surgical's Da Vinci 5 Surgical System, Analyst Outlines Sees Long-Term Growth Potential
March 15, 2024
From Benzinga
FDA Conditionally Approves Madrigal Pharmaceuticals' Resmetirom As First Treatment For Fatty Liver Disease With Scarring
March 15, 2024
From Benzinga
What's Going On With Cancer Focused-Geron Stock On Friday?
March 15, 2024
From Benzinga
GOP Sen. John Cornyn Takes Health Secretary To Task Over Cannabis Rescheduling: Xavier Becerra Holds His Own
March 14, 2024
From Benzinga
Geron Stock Is Soaring After Hours: What's Going On?
March 14, 2024
From Benzinga
FDA Approves Mirum's Livmarli For Liver Disease In Kids As Young As 5 Years: Analyst Bullish On Label Expansion Strategy
March 14, 2024
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.